Abstract
Hyperimmunoglobulinemia D with periodic fever syndrome (HIDS) is a recessively inherited recurrent fever syndrome. We describe a family of eldest son and monozygotic twin younger sisters with characteristic syndrome of HIDS, but normal level of IgD. Mevalonate kinase (MK) activity was deficient in all of them, and analysis of the MVK gene revealed compound heterozygosity for 2 new mutations, one of which was the disease-causing splicing mutation and the other was a novel missense mutation. All the patients had the same compound heterozygous mutations c.227-1 G > A and c.833 T > C, which resulted in exon 4 skipping and p.Val278Ala. This is the first case in which exon skipping mutation of the MVK gene has been certainly identified at the genomic DNA level. In each case, in which HIDS is clinically suspected, despite normal IgD level, analysis of MK activity and the MVK gene should be performed.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) is a rare autosomal recessive auto-inflammatory disorder characterized by recurrent febrile attacks with lymphadenopathy, abdominal distress, skin eruptions, and joint involvement [1–3]. Febrile attacks usually last for 3–7 days and are interrupted by asymptomatic intervals of several weeks’ duration [4–6]. Symptoms appear in early infancy and may persist throughout life with gradual increases in serum IgD [7, 8]. The diagnostic hallmark of HIDS is a constitutively elevated level of serum IgD, although parts of the patients have been reported to have normal amount of serum IgD levels.
The HIDS is caused by mutations on mevalonate kinase gene (MVK), which encodes an enzyme involved in cholesterol and non-sterol isoprenoid biosynthesis. We present herein a Japanese family, eldest son and monozygotic twin younger sisters, with HIDS that had compound heterozygous mutations on MVK gene, one of which was the disease-causing splicing mutation and the other was a novel missense mutation. Serum concentrations of IgD were repeatedly within the normal range. These cases demonstrate that detail analysis with more specific diagnostic tests such as urinary excretion of mevalonic acid and MVK genetic analysis should be performed not to miss the correct diagnosis in patients, especially younger children with HIDS.
Case reports
Patients are the eldest son and monozygotic twin younger sisters of parents of Japanese origin. The eldest son (patient 1) had presented with recurrent fever from 5 months of age. The twin younger sisters (patient 2 and 3) presented with fever from 1 month of age. Vomiting and diarrhea were presented in the younger sister (patient 3). Febrile episodes appeared every 4–8 weeks and lasted for 3–5 days on all the three patients. During febrile episodes, peripheral blood leukocytosis and CRP elevations (more than 10 mg/dl) were observed. In intermittent period between fever episodes, serum CRP levels decreased, but did not always become negative. Their parents had no history of recurrent fever. Sepsis work-up did not show any foci and any pathogens causing the febrile episodes. The repeated bacterial cultures resulted in negative, and administration of the antimicrobial agents did not change the clinical courses of the febrile episodes, indicating that the fever was not induced by pathogen. In addition, immunological analysis such as serum IgA, IgM, IgG, and IgD, lymphocytes counts including T, B, NK cells, and mitogen proliferation assays of peripheral blood mononuclear cells (PBMCs) were normal.
Due to the recurrent high fevers caused most unlikely by pathogen and the heavy family history of the periodic fevers, we suspected hereditary periodic fever syndromes and performed genetic study. After written informed consents approved by institutional review board of the Kyoto University Hospital were obtained, peripheral blood samples were collected from the patients and their parents for isolating genomic DNA and total RNA.
First, we performed genomic DNA sequencing for MEFV gene for familial Mediterranean fever, MVK gene for HIDS, NLRP3 for cryopyrin-associated periodic syndrome, and TNFRSF1A for TNF receptor-associated periodic syndrome. Genomic DNA sequencing analysis of the MVK gene revealed the presence of heterozygous mutations of c.227-1 G > A at the exon/intron border of exon 4 and c.833T > C (p.Val278Ala). Subsequent amplification of the cDNA by RT-PCR showed that the former mutation caused deletion of exon 4 (Fig. 1a). Genomic DNA sequence analysis on their parents revealed that the parents inherited c.227-1 G > A from their father and c.833T > C from their mother, indicating that the three patients were compound heterozygous for MVK gene (Fig. 1b). The patients had markedly elevated excretion of mevalonic acid in urine, especially in febrile periods, and their mevalonate kinase enzyme activities were very low, which confirmed that all the three patients suffered from HIDS (Table 1).
While the patients did not have any mutations on TNFRSF1A and NLRP3, we identified MEFV non-synonymous nucleotide alterations on the elder brother, who was a heterozygote for L110P, E148Q, and R202Q, and the younger twin, who was a heterozygote for R202Q in addition to MVK gene mutations. These MEFV gene nucleotide alterations were regarded as SNPs, and the clinical diagnosis of FMF was not compatible with the patients, although the complex MEFV gene alterations of L110P/E148Q/R202Q have been reported on the clinically-diagnosed FMF patients.
Discussion
We present herein a sibling of HIDS that demonstrated compound heterozygous for two novel mutations of MVK gene. All the patients had the same compound heterozygous mutations c.227-1 G > A and c.833T > C, which resulted in exon 4 skipping and p.Val278Ala. The mutations are novel, especially the splicing mutation of MVK gene was identified at the genomic DNA level.
Cuisset et al. [9] reported that HIDS mutations were evenly distributed along the coding region of the MVK gene, in contrast to mutations causing MA, which clustered between 243 and 334. The sequence variations seen in MA are missense mutations that are in the same region as the variants described in HIDS. Further studies will be needed to clarify the association of phenotypical differences with MVK gene mutations. Over 80% of patients with HIDS were reported to have compound heterozygous mutation in the MVK gene. To our knowledge, both the skipping of exon 4 and V278A mutation have not been reported previously in HIDS. Moreover, this is the first case in which exon skipping mutation of the MVK gene has been certainly identified at the genomic DNA level. Only few groups reported HIDS patients with the skipping of exon in the cDNA of the MVK gene [10, 11]. They suggested that these exon skipping was probably due to the presence of a potential splice site mutation, but could not identify mutations responsible for these altered splicing through the sequence analysis at the genomic level. Most MVK mutations in patients with HIDS and MA have only been determined at the cDNA level; however, analysis of cDNA sometimes appeared troublesome, probably due to instability of the MVK mRNA. More detailed studies through the sequence analysis at the genomic level lead us to elucidate the role of MVK mutations in HIDS and MA, and expression studies in E. coli will be necessary to evaluate the effect of each mutation.
HIDS is classically defined as a high concentration of mevalonic acid in the urine and is characterized by a high serum IgD concentration during each febrile episode, but some reports from the Netherlands stated that high levels of serum IgD levels were not seen and affirmed that other diseases also showed high serum IgD levels [12]. In our cases, the analysis of enzymes and molecular genetics of MVK gene yielded the correct diagnosis, although serum concentrations of IgD were within the normal range. Thus, it should be now common practice to examine the MVK gene in order to diagnose this disease.
In conclusion, we present a Japanese family with HIDS that appeared to have novel mutations of MVK gene. Most of the HIDS cases were reported from European, especially Dutch, whereas only one HIDS case of Japanese patient was reported by Naruto et al. [13], which is only one report of Asian patient. Cases of HIDS may so far have been overlooked or misdiagnosed as infectious diseases or autoimmune disorders in Japan, besides there may be difference in race. It is necessary that accumulation of case in hereditary mutation and in other race leads to solve a detailed cause of HIDS.
References
van der Meer JW, Vossen JM, Radl J, Van Nieuwkoop JA, Meyer CJ, Lobatto S et al (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1:1087–1090
Church LD, Churchman SM, Hawkins PN, McDermott MF (2006) Hereditary auto-inflammatory disorders and biologics. Semin Immunopathol 27:494–508
Simon A, van der Meer JW (2007) Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol 292:R86–R98
Fenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M et al (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobuninaemia D. Rheumatology (Oxford) 40:579–584
Stojanov S, Lohse P, Lohse P, Hoffmann F, Renner ED, Zellerer S et al. (2004) Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum 50:1951–1958
Touitous I, Lesage S, McDermott M, Cuisset L, Hoffman H, Dode C et al (2004) Infevers: an evolving mutation database for autoinflammatory syndromes. Hum Mutat 24:194–198
Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118–136
Haas D, Hoffmann GF (2006) Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis 1:13
Cuisset L, Drenth JP, Simon A, Vincent MF, Van der Velde Visser S, Van der Meer JW (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 9(4):260–266
Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG et al (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181
Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48:2645–2651
Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Bartimore) 73:133–144
Naruto T, Nakagishi Y, Mori M, Miyamae T, Imagawa T, Yokota S (2009) Hyper-IgD syndrome with novel mutation in Japanese girl. Mod Rheumatol 19(1):96–99
Acknowledgments
The authors thank Dr. Georg F. Hoffmann for measurement regarding the mevalonic kinase activity.
Conflict of interest
There is no financial or other potential conflict of interest for each author.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mizuno, T., Sakai, H., Nishikomori, R. et al. Novel mutations of MVK gene in Japanese family members affected with hyperimmunoglobulinemia D and periodic fever syndrome. Rheumatol Int 32, 3761–3764 (2012). https://doi.org/10.1007/s00296-011-2225-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2225-z